RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback